The Biotech Brief podcast

1: Changing the Game in HIV Prevention

0:00
3:19
Rewind 15 seconds
Fast Forward 15 seconds

In the first episode of The Biotech Brief, we break down what Yeztugo is, why it matters, how it compares to daily pills, and what this means for the $45 billion HIV prevention market.

More episodes from "The Biotech Brief"